ML 315( —— )

Catalog No. M34876 CAS No. 1440251-53-5

ML 315 is a selective Clk and DYRK inhibitor with potential anticancer activity for the study of neurological disorders.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	67	Get Quote
5MG	93	Get Quote
10MG	155	Get Quote
25MG	319	Get Quote
50MG	523	Get Quote
100MG	732	Get Quote
500MG	1467	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

ML 315
Note

Research use only, not for human use.
Brief Description

ML 315 is a selective Clk and DYRK inhibitor with potential anticancer activity for the study of neurological disorders.
Description

ML 315 is a selective dual inhibitor of CDK and DYRK with IC50s of 68 nM and 282 nM, respectively. ML 315 is used in cancer and neurological disease research.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

DYRK | CDK
Research Area

——
Indication

——

Chemical Information

CAS Number

1440251-53-5
Formula Weight

374.22
Molecular Formula

C18H13Cl2N3O2
Purity

>98% (HPLC)
Solubility

——
SMILES

ClC=1C=C(Cl)C=C(C1)CNC=2N=CN=CC2C3=CC=C4OCOC4=C3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Coombs TC, et al. Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun 15;23(12):3654-61.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks